These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4545706)

  • 1. Transformability of group H streptococcus challis. I. Diminution and acquisition of transformability in alpha-hemolytic variants of group H streptococcus challis.
    Ito T; Hirano T; Tomura T; Yoshioka M
    Jpn J Microbiol; 1973 Nov; 17(6):431-7. PubMed ID: 4545706
    [No Abstract]   [Full Text] [Related]  

  • 2. Transformability of group H Streptococcus challis. II. Transformation of hemolytic activity and competence-provoking factor nonproducibility.
    Ito T; Hirano T; Tomura T; Yoshioka M
    Jpn J Microbiol; 1973 Nov; 17(6):439-44. PubMed ID: 4599107
    [No Abstract]   [Full Text] [Related]  

  • 3. Transformability of streptomycin-resistant group H streptococci.
    Perry D
    J Bacteriol; 1968 Jan; 95(1):132-8. PubMed ID: 5636810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of 14C-streptomycin by streptomycin-sensitive and streptomycin-resistant group H streptococci.
    Perry D
    J Bacteriol; 1969 Feb; 97(2):518-21. PubMed ID: 5773007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of mitomycin C, actinomycin C and some other antibiotics on the transformation of streptococci].
    Klimov AN; Maiuga OA; Tereshin IM
    Antibiotiki; 1966 Sep; 11(9):785-8. PubMed ID: 4172492
    [No Abstract]   [Full Text] [Related]  

  • 6. The mechanism of competence in the transformation of streptococci of serological group H. Transformation of the marker of the competence factor from S. challis to S. wicky.
    Dobrzański WT; Nalecz J; Rajchert-Trzpil M
    Mol Gen Genet; 1970; 108(4):312-21. PubMed ID: 5495903
    [No Abstract]   [Full Text] [Related]  

  • 7. Transformation of Streptococcus sanguis to intrinsic penicillin resistance.
    Zito ET; Daneo-Moore L
    J Gen Microbiol; 1988 May; 134(5):1237-49. PubMed ID: 3199097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular sites for the competence-provoking factor of streptococci.
    Pakula R
    J Bacteriol; 1967 Jul; 94(1):75-9. PubMed ID: 6028002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic medium for development of competence and transformation in Streptococcus challis.
    Osowiecki H; Dobrzanski WT
    Pathol Microbiol (Basel); 1968; 31(4):226-32. PubMed ID: 5667675
    [No Abstract]   [Full Text] [Related]  

  • 10. [Change in the antibiogram of various often occurring pathogenic bacterial species and the resulting significance of carbencillin].
    Legler F
    Arch Hyg Bakteriol; 1970 Jun; 154(1):28-36. PubMed ID: 4920202
    [No Abstract]   [Full Text] [Related]  

  • 11. Nuclease content of group H Streptococcus strain Challis cell surface extracts inactivating transforming deoxyribonucleic acid.
    Starościak BJ; Ceglowski P; Dobrzański WT
    J Bacteriol; 1975 Jul; 123(1):174-8. PubMed ID: 1141194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of D-cycloserine on transformation in group H streptococcus, strain Challis.
    Perry D
    J Bacteriol; 1972 Mar; 109(3):1014-9. PubMed ID: 5011243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of transformable and nontransformable isolates derived from two strains of streptococci.
    Pakula R; Spencer LR; Anderson N; Goldstein PA
    Can J Microbiol; 1973 Feb; 19(2):207-16. PubMed ID: 4696780
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic resistant group A streptococci. II. General characteristics of beta-hemolysis restored organisms derived from alpha-hemolytic mutants.
    Yoshioka M; Konuma T; Kunii T
    Jpn J Microbiol; 1966 Apr; 10(1):33-42. PubMed ID: 5335401
    [No Abstract]   [Full Text] [Related]  

  • 15. Method and parameters for genetic transformation of Streptococcus sanguis Challis.
    Pozzi G; Musmanno RA; Lievens PM; Oggioni MR; Plevani P; Manganelli R
    Res Microbiol; 1990; 141(6):659-70. PubMed ID: 2284501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DRUG-RESISTANCE OF STREPTOCOCCUS VIRIDANS AND STREPTOCOCCUS HEMOLYTICUS].
    MIKATA I; TOMIOKA H
    J Antibiot B; 1964 Jun; 17():119-26. PubMed ID: 14201524
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.
    Durack DT; Pelletier LL; Petersdorf RG
    J Clin Invest; 1974 Mar; 53(3):829-33. PubMed ID: 4492776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the difference of group and type distribution of susceptibility of beta hemolytic streptococci among Tokyo, Fukushima and Okinawa Prefectures (author's transl)].
    Oguri T; Shidara M; Kosakai N; Tadano J
    Jpn J Antibiot; 1974 Feb; 27(1):1-7. PubMed ID: 4546294
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tetracycline resistance in beta-hemolytic streptococci and pneumococci].
    Pulverer G
    Dtsch Med Wochenschr; 1967 Sep; 92(36):1608-12. PubMed ID: 4383130
    [No Abstract]   [Full Text] [Related]  

  • 20. Penicillin combined with gentamicin or streptomycin: synergism against enterococci.
    Watanakunakorn C
    J Infect Dis; 1971 Dec; 124(6):581-6. PubMed ID: 5209849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.